About this trial

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

Eligibility criteria

Qualifiers

Males and females of diverse racial and ethnic backgrounds, with age across the lifespan;

Patients will have at least one of the forms of dystonia, including focal dystonia (e.g., laryngeal, cervical, oromandibular, blepharospasm, focal hand, musicians), segmental dystonia, or generalized dystonia;

Patients will have other movement disorders (Parkinson's disease, essential tremor, dyskinesia, myoclonus) and other non-neurological conditions (tic disorders, torticollis, ulnar nerve entrapments, temporomandibular disorders, dysphonia) that mimic dystonic symptoms.

Disqualifiers

Patients who are incapable of giving informed consent;

Patients who are unable to undergo brain MRI due to the presence of certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed or due to pregnancy or breastfeeding at the time of the study.

Trial design

Treatments tested in this trial

  • DystoniaNet-based diagnosis of isolated dystonia

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Locations

1
Massachusetts Eye and Ear Infirmary02114, BostonMassachusetts, United States

Sponsors and collaborators

Massachusetts Eye and Ear Infirmary

Lead sponsor